Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of the National Cancer Institute

• Publication date

  2002-11-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNCI/94.21.1604PMID 12419786
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of the herpes simplex virus.

  2002cited by this paper
• Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.

  2002influential reference
• Breast cancer prevention.

  2002cited by this paper
• Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas.

  2001cited by this paper
• Interferon (IFN)-gamma and Herpes simplex virus/tumor necrosis factor-alpha synergistically induce nitric oxide synthase 2 in macrophages through cooperative action of nuclear factor-kappa B and IFN regulatory factor-1.

  2001cited by this paper
• Prevalence and Risk Factors for Herpes Simplex Virus Type 2 Infection Among Middle-Age Women in Brazil and the Philippines

  2001cited by this paper
• Statistical methods in cancer research

  2001cited by this paper
• HPV types and cofactors causing cervical cancer in Peru

  2001cited by this paper
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

  1999influential reference
• Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.

  1999cited by this paper
• Causes of cervical cancer in the Philippines: a case-control study.

  1998cited by this paper
• Human Papillomavirus

  1998cited by this paper
• Risk factors for cervical cancer in Thailand: a case-control study.

  1998cited by this paper
• Relationship of stable integration of herpes simplex virus‐2 BglII N subfragmentXho2 to malignant transformation of human papillomavirus‐immortalized cervical keratinocytes

  1998cited by this paper
• The viral origin of cervical cancer in Rabat, Morocco

  1998cited by this paper
• Type specific antibodies to HSV-1 and -2

  1998cited by this paper
• Effect of herpes simplex virus on the DNA of human papillomavirus 18

  1997cited by this paper
• A sero‐epidemiological study of the relationship between sexually transmitted agents and cervical cancer in Honduras

  1997cited by this paper
• Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study

  1996cited by this paper
• The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.

  1996cited by this paper
• Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women.

  1996cited by this paper
• IARC Monographs on the Evaluation of Carcinogenic Risks to Humans

  1995cited by this paper
• Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes

  1995cited by this paper
• Human Papillomavirus Infection Is Transient in Young Women: A PopulationBased Cohort Study

  1995cited by this paper
• Human papillomavirus infection is transient in young women: a population-based cohort study.

  1995cited by this paper
• Lifetime Number of Partners As the Only Independent Risk Factor for Human Papillomavirus Infection: A Population‐Based Study

  1995cited by this paper
• Cervical cancer: is herpes simplex virus type II a cofactor?

  1995cited by this paper
• The presence of persistent high‐risk hpv genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months

  1995cited by this paper
• Cervical cancer and herpes simplex virus type 2: Case‐control studies in Spain and Colombia, with special reference to immunoglobulin‐G sub‐classes

  1995cited by this paper
• Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations

  1994cited by this paper
• Sexually transmitted agents and cervical neoplasia in colombia and Spain

  1994cited by this paper
• A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes.

  1994cited by this paper
• A population-based seroepidemiological study of cervical cancer.

  1994influential reference
• Human papillomavirus and invasive cervical cancer in Brazil.

  1994cited by this paper
• Determinants of Genital Human Papillomavirus Infection in Low‐Income Women in Washington, D.C

  1993cited by this paper
• Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk.

  1993influential reference
• Epidemiology of cervical cancer--overview.

  1992cited by this paper
• The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spain

  1992influential reference
• Epidemiology of cervical cancer--overview.

  1992cited by this paper
• State of the art regarding evidence of the viral origin of cervical cancer.

  1991cited by this paper
• Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2.

  1991cited by this paper
• Herpes simplex virus type 2: A possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer

  1991influential reference
• Human papillomavirus types 16 and 33, herpes simplex virus type 2 and other risk factors for cervical cancer in sichuan province, china

  1991cited by this paper
• Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera

  1988cited by this paper
• Herpes simplex type 2 virus and cervical neoplasia.

  1987cited by this paper
• The oncogenic potential of herpes simplex viruses: evidence for a ‘hit-and-run’ mechanism

  1983cited by this paper
• Detection of herpes simplex virus type‐2 DNA restriction fragments in human cervical carcinoma tissue.

  1983cited by this paper
• Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events?

  1982cited by this paper
• Sex partners and herpes simplex virus type 2 in the epidemiology of cancer of the cervix.

  1982cited by this paper
• Statistical methods in cancer research: volume 1- The analysis of case-control studies

  1980cited by this paper
• Oncogenesis and Herpesviruses II

  1976cited by this paper
• Antibodies to herpesviruses in patients with cervical cancer and controls.

  1975cited by this paper
• Transformation of rat embryo cells by temperature-sensitive mutants of herpes simplex virus.

  1974cited by this paper
• MUTANTS OF HERPES SIMPLEX VIRUS

  1972cited by this paper
• Herpesvirus type 2: association with carcinoma of the cervix.

  1969cited by this paper

• High-Risk Human Papillomavirus and Other Sexually Transmitted Infections Among Women Living With Human Immunodeficiency Virus in Jos, Nigeria

  2026cites this paper
• High throughput HPV genotyping by next generation sequencing for detection of 28 HPV types and 13 sexually transmitted infections: A first community-based cervical cancer screening study from India.

  2026cites this paper
• Cofactors in Human Papillomavirus Carcinogenesis.

  2026cites this paper
• Human Papillomavirus and Other Relevant Issues in Cervical Cancer Pathogenesis

  2025cites this paper
• Syndemic Synergy of HPV, HIV, and HSV-2 for Oncogenic HPV Replication in Female Sex Workers

  2025cites this paper
• High prevalence and incidence of HSV-2 among people who inject drugs in Hai Phong, Vietnam, and risk factors associated with seroconversion

  2025cites this paper
• Anxiety and depression levels among obstetrics and gynecology physicians in the management of HPV-positive patients

  2025cites this paper
• Investigation of the Prevalence of High-Risk Human Papillomavirus, Human Herpesvirus-8, and Herpes Simplex Virus-2 in Cervical Biopsy Samples Using the Real-Time PCR Method

  2025cites this paper
• A review of HSV pathogenesis, vaccine development, and advanced applications

  2024cites this paper
• The Impact of Diagnosis of Human Papillomavirus (HPV) Infection and Electrosurgical Excision Procedure (LEEP) for Cervical Intraepithelial Neoplasia 3 (CIN3) on Women’s Sexual Lives

  2024cites this paper
• Prevalence of bacterial vaginosis, sexually transmitted infections and their association with HPV infections in asymptomatic women attending antenatal care in Ethiopia

  2024cites this paper
• Association of Herpes simplex infection with significantly increased risk of head and neck cancer: real‐world evidence of about 500,000 patients

  2024cites this paper
• Herpes simplex virus type 2 in sub-Saharan Africa and the potential impact of helminth immune modulation

  2024cites this paper
• Declining Prevalence of Human Papillomavirus Co‐Infections Among Young Japanese Women With Cervical Cancer and Its Precursors

  2024cites this paper
• Seroprevalence of antibodies against herpesvirus type 2 in a female prison population in Mato Grosso

  2023cites this paper
• Association between human papillomavirus infection and common sexually transmitted infections, and the clinical significance of different Mycoplasma subtypes

  2023cites this paper
• Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis

  2023cites this paper
• Evaluation of Baghdad University females student’s knowledge about cervical cancer and effect of antioxidants vitamins on its occurrence

  2023cites this paper
• Detection of Chlamydia trachomatis and Herpes Simplex Virus-2 Infections Among Clinically Suspected Women with Cervical Cancer or Precancerous Lesions

  2023cites this paper
• DETECTION OF P16/KI-67 MARKERS IN THE DETECTION OF CERVICAL INTRAEPITHELIAL NEOPLASIA

  2023cites this paper
• HSV-2 infection and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV

  2023cites this paper
• Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients

  2023cites this paper
• Hookworm infection associates with a vaginal Type 1/Type 2 immune signature and increased HPV load

  2022cites this paper
• Herpes Virus Simple tipo 2 ¿factor y/o cofactor en el cáncer del cuello uterino? Revisión narrativa de la literatura

  2022cites this paper
• COVID-19 Pandemic Effects on Cervical Cancer Diagnosis and Management: A Population-Based Study in Romania

  2022cites this paper
• Risk factors and communities disproportionately affected by cervical cancer in the Russian Federation: A national population-based study

  2022cites this paper
• Influence of NECTIN1 Gene Variants in Herpesvirus Infection in Patients with Thyroid Nodules

  2022cites this paper
• Novel prognostic nomograms in cervical cancer based on analysis of 1075 patients

  2022cites this paper
• Cancer cervix: Epidemiology and disease burden

  2022cites this paper
• The association of HPV infection and vaginal microbiota of reproductive women in China: A multicenter cohort study protocol

  2022cites this paper
• Association between common vaginal and HPV infections and results of cytology test in the Zhoupu District, Shanghai City, China, from 2014 to 2019

  2022cites this paper
• Investigation of the association between ten pathogens causing sexually transmitted diseases and high-risk human papilloma virus infection in Shanghai

  2021cites this paper
• The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis

  2021cites this paper
• Epidemiology of herpes simplex virus type 2 in Latin America and the Caribbean: systematic review, meta-analyses and metaregressions

  2021cites this paper
• Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme

  2021cites this paper
• Detection of sexually transmitted pathogens and co-infection with human papillomavirus in women residing in rural Eastern Cape, South Africa

  2021cites this paper
• Prevalence of cervical HPV infection, sexually transmitted infections and associated antimicrobial resistance in women attending cervical cancer screening in Mali.

  2021cites this paper
• Quantifying the Effects of Medical Examination and Possible Risk Factors against the Incidence of Cervical Cancer in a Low Human Papillomavirus Vaccination Coverage: An Ecological Study in Japan

  2021cites this paper
• Epstein-Barr virus, human papillomavirus and herpes simplex virus 2 co-presence severely dysregulates miRNA expression

  2021cites this paper
• Cervical cancer in the era of precision medicine: A perspective from developing countries

  2021cites this paper
• Association between viral infection other than human papillomavirus and risk of esophageal carcinoma: a comprehensive meta-analysis of epidemiological studies

  2021cites this paper
• Human Viruses: Infection, Prevention and Potential Target(s) for Therapy – A Comprehensive Review

  2021cites this paper
• Detection of aflatoxin B1 adducts in Mexican women with cervical lesions

  2021cites this paper
• A comprehensive HPV-STI NGS assay for detection of 29 HPV types and 14 non-HPV sexually transmitted infections

  2021cites this paper
• Current vaccine approaches and emerging strategies against herpes simplex virus (HSV)

  2021cites this paper
• Prevalence of sexually transmitted infections among cervical cancer suspected women at University of Gondar Comprehensive Specialized Hospital, North-west Ethiopia

  2021cites this paper
• Functional activities of beta-glucans in the prevention or treatment of cervical cancer

  2020cites this paper
• The Cervicovaginal Mucus Barrier

  2020cites this paper
• Co-existence of Herpes simplex virus type 2 and two other oncoviruses is associated with cervical lesions in women living with HIV in South-Western Nigeria

  2020cites this paper
• Cancers of the Cervix, Vulva, and Vagina

  2020cites this paper
• HPV and Cervical Cancer Screening Awareness: A Case-control Study in Nigeria

  2020cites this paper
• Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort

  2020cites this paper
• Incidence and risk factors for HPV-associated cancers in women with end-stage renal disease

  2020cites this paper
• Prevalence of viral sexually transmitted infections and HPV high-risk genotypes in women in rural communities in the Department of La Paz, Bolivia

  2020cites this paper
• Human alpha and beta herpesviruses and cancer: passengers or foes?

  2020cites this paper
• Overview of virus and cancer relationships. Position paper

  2020cites this paper
• Association of sexually transmitted infections and human papillomavirus co-infection with abnormal cervical cytology among women in Saudi Arabia

  2020cites this paper
• Prevalence and prevention of sexually transmitted viral infections in women from the Bolivian Amazonas

  2020cites this paper
• Prevalence of active infection by herpes simplex virus type 2 in patients with high‐risk human papillomavirus infection: A cross‐sectional study

  2020influential citation
• Associations of sexually transmitted infections and bacterial vaginosis with abnormal cervical cytology: A cross-sectional survey with 9090 community women in China

  2020cites this paper
• The Effect of Progesterone Only Contraception on the Accuracy of Cervical Cytologic interpretation

  2019influential citation
• MRI and CT of the Female Pelvis

  2019cites this paper
• Herpes simplex virus type 1 epidemiology in Latin America and the Caribbean: Systematic review and meta-analytics

  2019influential citation
• FACTORS ASSOCIATED WITH PERSISTENCE OF HPV GENITAL INFECTION IN A SMALL COHORT OF ROMANIAN WOMEN

  2019cites this paper
• Characteristics of HSV-2, M.genitalium and C.trachomatis in HPV genotypes- associated Cervical Cancer and Genital Infections...

  2019cites this paper
• Cervical Cancer Screening in Women With Severe Mental Disorders: An Approach to the Spanish Context.

  2019cites this paper
• Incidence and mortality of cervix cancer and their relationship with the human development index in 185 countries in the world: An ecology study in 2018

  2019cites this paper
• Self-collected versus clinician-collected samples for HSV-2 and HSV-2/HPV screening in HIV-infected and -uninfected women in the Tapajós region, Amazon, Brazil

  2019cites this paper
• A retrospective study of clinicopathological profile of carcinoma cervix and incidence of various postoperative complications

  2019cites this paper
• Factors associated with HPV and other self-reported STI coinfections among sexually active Brazilian young adults: cross-sectional nationwide study

  2019cites this paper
• Clinical, Cytological and Genotypic Correlation between Oral Mucosa and Lower Genital Tract Lesions Related to HPV Infection in Women

  2019cites this paper
• Role of polycyclic aromatic hydrocarbons as a co-factor in human papillomavirus-mediated carcinogenesis

  2019cites this paper
• Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review)

  2018cites this paper
• Co-Infection Prevalence of Herpes Simplex Virus Types 1 and 2 with Human Papillomavirus and Associated Risk Factors among Asymptomatic Women in Ghana

  2018cites this paper
• Adherence to gynecological screening impacted by experienced orthodontic treatment in childhood

  2018cites this paper
• Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways

  2018cites this paper
• HPV: Molecular pathways and targets.

  2018cites this paper
• Herpesviruses (Herpesviridae)

  2018cites this paper
• Female genital mutilation and noninvasive cervical abnormalities and invasive cervical cancer in Senegal, West Africa: A retrospective study

  2018cites this paper
• Human papillomaviruses in Western Africa: prevalences and risk factors in Burkina Faso

  2018cites this paper
• Cervical Cancer Prevention and Control

  2018cites this paper
• Natural History of Human Papillomavirus Infections and Other Sexually Transmitted Infections in Rwanda-Immunological Aspects of the Uterine Cervix

  2018cites this paper
• Detection of sexually transmitted infections at a Brazilian gynecology center: high prevalence of co-infections

  2018cites this paper
• Beating Cervical Cancer in

  2018cites this paper
• Innate immune factors in recurrent and persistent infections of the lower female genital tract

  2018cites this paper
• Herpes Simplex Virus Type 2: Bystander or Active Player in Cervical Carcinogenesis?

  2018cites this paper
• Cervical Cancer Induction Enhancement Potential of Chlamydia Trachomatis: A Systematic Review

  2018cites this paper
• RETRACTED ARTICLE: Impact of Toll-Like Receptors 2/3/4/9, IL-1-α/β and TNF-α Polymorphisms in Cervical Cancer Susceptibility in Tunisia

  2018cites this paper
• Seropositivity to herpes simplex virus type 2, but not type 1 is associated with cervical cancer: NHANES (1999–2014)

  2017cites this paper
• Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial

  2017cites this paper
• Analyse fonctionnelle des polymorphismes du virus du papillome humain de type 33

  2017cites this paper
• A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus

  2017cites this paper
• Spontaneous clearance of the human papilloma virus as a result of suppressive therapy with acyclic nucleosides of a recurrent herpes-viral infection

  2017cites this paper
• Manejo conservador de lesiones de alto grado cervicales en mujeres jóvenes. Estudio longitudinal prospectivo

  2017cites this paper
• Laryngopharyngeal reflux and herpes simplex virus type 2 are possible risk factors for adult‐onset recurrent respiratory papillomatosis (prospective case–control study)

  2017cites this paper
• Risk of high-risk human papillomavirus infection and cervical precancerous lesions with past or current trichomonas infection: a pooled analysis of 25,054 women in rural China.

  2017cites this paper
• DNA-In Situ Hybridization for Molecular Localization of Human Cytomegalovirus in Cervical Tissues from Iraqi Patients with Cervical Adenocarcinoma

  2017cites this paper
• Analysis of cervical lesions for presence of HSV-2 and HPV-16 and HPV-18 in Iranian patients by PCR

  2017cites this paper
• Socio-Demographic, Reproductive and Clinical Profile of Women Diagnosed with Advanced Cervical Cancer in a Tertiary Care Institute of Delhi

  2017cites this paper
• Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa

  2017cites this paper